Search
Junior membership
If you're at an early stage in your career, junior membership can be a great way to:
Expand your knowledge
Make connections
Access EHA's early career opportunities
Stay up to date with the latest developments
As a junior member, you can also apply for EHA…
Compliance and reports
EHA is a non-governmental and not-for-profit membership organization that is guided by its mission to promote excellence in patient care, research, and education in hematology.
Read moreCall for interest — new La Cantera event
The call for interest is closed at 23:59 on November 30, 2024. In 2025, EHA will provide funding for a new La Cantera coaching event.
Read moreFrom bedside to Brussels: hematology at the forefront of EU health policy
Access is at the heart of EHA's European Affairs work. More specifically, equitable and affordable access to innovative therapies that are of clear added benefit from a clinical, patient, and public health perspective.
Read moreChoose your membership
Wherever you are in the world, you can join our vibrant community and benefit from our rigorous resources and career-enhancing opportunities.
Read moreHealthcare-affiliated professional membership
You don't need to be scientific researcher or a physician to join our vibrant community.
Read moreEmeritus membership
If you're a scientific researcher, physician, or healthcare-affiliated professional who's now retired or is close to retirement, you can join EHA at a reduced rate.
Read moreFull membership
Our most popular type of membership is designed for established scientific researchers and physicians.
Read moreClinical Research Training in Hematology
The CRTH 2025 call for applications is now closed. What is Clinical Research Training in Hematology (CRTH)?Clinical Research Training in Hematology (CRTH) provides early-career researchers with a unique, 9-month long training and mentoring experience.
Read moreEHA Guidelines by Topic
AL Amyloidosis
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines (2021)
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group (2022)
Anemia
Recommendations regarding splenectomy in hereditary hemolytic anemias (2017)
Management of…